| Ident. | Authors (with country if any) | Title |
|---|
| 000353 (2006) |
Alexandre Castro-Caldas [Portugal] ; Paul Delwaide [Belgique] ; Wolfgang Jost [Allemagne] ; Marcelo Merello [Argentine] ; Adrian Williams [Royaume-Uni] ; Paolo Lamberti [Italie] ; Miguel Aguilar [Espagne] ; Susanna Del Signore [France] ; Pierre Cesaro [France] | The Parkinson–Control study: A 1‐year randomized, double‐blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease |
| 000355 (2006) |
Tanja Schmitz-Hübsch [Allemagne] ; Sophie Tezenas Du Montcel [France] ; Laszlo Baliko [Hongrie] ; Sylvia Boesch [Autriche] ; Sara Bonato [Belgique] ; Roberto Fancellu [Italie] ; Paola Giunti [Royaume-Uni] ; Christoph Globas [Allemagne] ; Jun-Suk Kang [Allemagne] ; Berry Kremer [Pays-Bas] ; Caterina Mariotti [Italie] ; Bela Melegh [Hongrie] ; Maryla Rakowicz [Pologne] ; Rafal Rola [Pologne] ; Sylvie Romano [Italie] ; Lodger Schöls [Allemagne] ; Sandra Szymanski [Allemagne] ; Bart P. C. Van De Warrenburg [Pays-Bas] ; Elzbieta Zdzienicka [Pologne] ; Alexandra Dürr [France] ; Thomas Klockgether [Allemagne] | Reliability and validity of the International Cooperative Ataxia Rating Scale: A study in 156 spinocerebellar ataxia patients |
| 000368 (2006) |
Aurélie Funkiewiez [France] ; Claire Ardouin [France] ; Roshan Cools [Royaume-Uni] ; Paul Krack [France] ; Valérie Fraix [France] ; Alina Batir [France] ; Stephan Chabardès [France] ; Alim-Louis Benabid [France] ; Trevor W. Robbins [Royaume-Uni] ; Pierre Pollak [France] | Effects of levodopa and subthalamic nucleus stimulation on cognitive and affective functioning in Parkinson's disease |
| 000369 (2006) |
Olivier Rascol [France] ; Bruno Dubois [France] ; Alexandre Castro Caldas [Portugal] ; Stephen Senn [Royaume-Uni] ; Susanna Del Signore [France] ; Andrew Lees (neurologue) [Royaume-Uni] | Early piribedil monotherapy of Parkinson's disease: A planned seven‐month report of the REGAIN study |
| 000371 (2006) |
Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Amos D. Korczyn [Israël] ; Peter P. De Deyn [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Anthony E. Lang [Canada] ; Mona Abdalla [Royaume-Uni] | Development of dyskinesias in a 5‐year trial of ropinirole and L‐dopa |
| 000378 (2006) |
Ali R. Rezai [États-Unis] ; Brian H. Kopell [États-Unis] ; Robert E. Gross [États-Unis] ; Jerrold L. Vitek [États-Unis] ; Ashwini D. Sharan [États-Unis] ; Patricia Limousin [Royaume-Uni] ; Alim-Louis Benabid [France] | Deep brain stimulation for Parkinson's disease: Surgical issues |
| 000383 (2006) |
Michael P. Hill [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni] ; Steven G. Mcguire [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni, Canada] ; Alan R. Crossman [Royaume-Uni] ; Catherine Rochat [France] ; Mark J. Millan [France] | Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP‐lesioned marmosets: Mediation by D2, not D3, dopamine receptors |
| 000384 (2006) |
Alexandre Castro-Caldas [Portugal] ; Paul Delwaide [Belgique] ; Wolfgang Jost [Allemagne] ; Marcelo Merello [Argentine] ; Adrian Williams [Royaume-Uni] ; Paolo Lamberti [Italie] ; Miguel Aguilar [Espagne] ; Susanna Del Signore [France] ; Pierre Cesaro [France] | The parkinson-control study : A 1-year randomized, double- blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in parkinson's disease |
| 000385 (2006) |
Tanja Schmitz-Hübsch [Allemagne] ; Sophie Tezenas Du Montcel [France] ; Laszlo Baliko [Hongrie] ; Sylvia Boesch [Autriche] ; Sara Bonato [Belgique] ; Roberto Fancellu [Italie] ; Paola Giunti [Royaume-Uni] ; Christoph Globas [Allemagne] ; Jun-Suk Kang [Allemagne] ; Berry Kremer [Pays-Bas] ; Caterina Mariotti [Italie] ; Bela Melegh [Hongrie] ; Maryla Rakowicz [Pologne] ; Rafal Rola [Pologne] ; Sylvie Romano [Italie] ; Lodger Schols [Allemagne] ; Sandra Szymanski [Allemagne] ; Bart P. C. Van De Warrenburg [Pays-Bas] ; Elzbieta Zdzienicka [Pologne] ; Alexandra Dürr [France] ; Thomas Klockgether [Allemagne] | Reliability and validity of the international cooperative ataxia rating scale : A study in 156 spinocerebellar ataxia patients |
| 000394 (2005) |
Eva Andermann [Canada] ; Adrian Danek [Allemagne] ; Glenn Irvine [Royaume-Uni] ; Hans H. Jung [Suisse] ; Luca Rampoldi [Italie] ; François Tison [France] ; Ruth H. Walker [États-Unis] | Second International Neuroacanthocytosis Symposium: Expanding the spectrum of choreatic syndromes: Montreal Neurological Hospital and Institute, April 17–19 |
| 000414 (2005) |
Serge Pinto [France, Royaume-Uni] ; Michèle Gentil [France] ; Paul Krack [France] ; Paul Sauleau [France] ; Valérie Fraix [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] | Changes induced by levodopa and subthalamic nucleus stimulation on parkinsonian speech |
| 000415 (2005) |
Stephane Thobois [Royaume-Uni, France] ; Stephen Tisch [Royaume-Uni] ; Jing Xie-Brustolin [France] ; Patrick Mertens [France] ; Marwan I. Hariz [Royaume-Uni] ; Isabelle Benatru [France] ; Emmanuel Broussolle [France] ; Patricia Limousin-Dowsey [Royaume-Uni] | Can chronic subthalamic nucleus stimulation induce de novo tremor in Parkinson's disease? |
| 000416 (2005) |
Dominique Caparros-Lefebvre [France] ; Andrew Lees (neurologue) [Royaume-Uni] | Atypical unclassifiable parkinsonism on Guadeloupe: An environmental toxic hypothesis |
| 000422 (2005) |
Dominique Caparros-Lefebvre [France] ; Andrew Lees (neurologue) [Royaume-Uni] | Atypical unclassifiable parkinsonism on guadeloupe : An environmental toxic hypothesis |
| 000424 (2004) |
Jan C. M. Zijlmans [Royaume-Uni, Pays-Bas] ; Berengere Debilly [France] ; Olivier Rascol [France] ; Andrew Lees (neurologue) [Royaume-Uni] ; Franck Durif [France] | Safety of entacapone and apomorphine coadministration in levodopa‐treated Parkinson's disease patients: Pharmacokinetic and pharmacodynamic results of a multicenter, double‐blind, placebo‐controlled, cross‐over study |
| 000432 (2004) |
C. Warren Olanow [États-Unis] ; Yves Agid [France] ; Yoshi Mizuno [Japon] ; Alberto Albanese [Italie] ; U. Bonucelli [Italie] ; Philip Damier [France] ; Justo De Yebenes [Espagne] ; Oscar Gershanik [Argentine] ; Mark Guttman [Canada] ; F. Grandas [Espagne] ; Mark Hallett [États-Unis] ; Ole Hornykiewicz [Autriche] ; Peter Jenner [Royaume-Uni] ; R. Katzenschlager [Royaume-Uni] ; William J. Langston [États-Unis] ; Peter Lewitt [États-Unis] ; Eldad Melamed [Israël] ; M. A. Mena [Espagne] ; P. P. Michel [France] ; Catherine Mytilineou [États-Unis] ; Jose A. Obeso [Espagne] ; Werner Poewe [Autriche] ; Niall Quinn [Royaume-Uni] ; R. Raisman-Vozari [France] ; Ali H. Rajput [Canada] ; Olivier Rascol [France] ; Christina Sampaio [Portugal] ; Fabrizio Stocchi [Italie] | Levodopa in the treatment of Parkinson's disease: Current controversies |
| 000436 (2004) |
Gregor K. Wenning [Autriche] ; Franc Ois Tison [France] ; Klaus Seppi [Autriche] ; Cristina Sampaio [Portugal] ; Anja Diem [Autriche] ; Farid Yekhlef [France] ; Imad Ghorayeb [France] ; Fabienne Ory [France] ; Monique Galitzky [France] ; Tommaso Scaravilli [Royaume-Uni] ; Maria Bozi [Royaume-Uni] ; Carlo Colosimo [Italie] ; Sid Gilman [États-Unis] ; Clifford W. Shults [États-Unis] ; Niall P. Quinn [Royaume-Uni] ; Olivier Rascol [France] ; Werner Poewe [Autriche] | Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS) |
| 000450 (2003) |
Michael P. Hill [Royaume-Uni] ; Erwan Bezard [France] ; Steven G. Mcguire [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Canada] ; Ann Michel [Belgique] ; Renee Grimée [Belgique] ; Henrik Klitgaard [Belgique] | Novel antiepileptic drug levetiracetam decreases dyskinesia elicited by L‐dopa and ropinirole in the MPTP‐lesioned marmoset |
| 000451 (2003) |
Jane E. Warren [Australie] ; Marie Vidailhet [France] ; Christopher S. Kneebone [Australie] ; Niall P. Quinn [Royaume-Uni] ; Philip D. Thompson [Australie] | Myoclonus in spinal dysraphism |
| 000468 (2002) |
Lance A. Smith [Royaume-Uni] ; Banu C. Tel [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Matthew J. Hansard [Royaume-Uni] ; Rogelio Braceras [Royaume-Uni] ; Céline Bonhomme [France] ; Claire Chezaubernard [France] ; Susanna Del Signore [France] ; Sarah Rose [Royaume-Uni] ; Peter Jenner [Royaume-Uni] | Repeated administration of piribedil induces less dyskinesia than L‐dopa in MPTP‐treated common marmosets: A behavioural and biochemical investigation |
| 000471 (2002) |
François Tison [France] ; Farid Yekhlef [France] ; Virginie Chrysostome [France] ; Eric Balestre [France] ; Niall P. Quinn [Royaume-Uni] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche] | Parkinsonism in multiple system atrophy: Natural history, severity (UPDRS‐III), and disability assessment compared with Parkinson's disease |
